List of Tables
    Table 1. Poliomycetes Vaccine CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Poliomycetes Vaccine Market Trends
    Table 3. Poliomycetes Vaccine Market Drivers
    Table 4. Poliomycetes Vaccine Market Challenges
    Table 5. Poliomycetes Vaccine Market Restraints
    Table 6. Global Poliomycetes Vaccine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Poliomycetes Vaccine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Poliomycetes Vaccine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Poliomycetes Vaccine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Poliomycetes Vaccine Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Poliomycetes Vaccine Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Poliomycetes Vaccine Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Poliomycetes Vaccine Sales by Manufacturer, (K Doses), 2017-2022
    Table 14. Global Poliomycetes Vaccine Sales Share by Manufacturer, 2017-2022
    Table 15. Global Poliomycetes Vaccine Price by Manufacturer (2017-2022) & (USD/Dose)
    Table 16. Global Poliomycetes Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Poliomycetes Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Poliomycetes Vaccine as of 2021)
    Table 18. Top Players of Poliomycetes Vaccine in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Poliomycetes Vaccine Product Type
    Table 20. Date of International Manufacturers Enter into Poliomycetes Vaccine Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Poliomycetes Vaccine Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Poliomycetes Vaccine Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Poliomycetes Vaccine Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Poliomycetes Vaccine Sales by Players, (K Doses), 2020, 2021 & 2022
    Table 26. United States Poliomycetes Vaccine Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Poliomycetes Vaccine Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Poliomycetes Vaccine Sales in Volume by Region (2017-2022) & (K Doses)
    Table 29. Global Poliomycetes Vaccine Sales in Volume Forecast by Region (2023-2028) & (K Doses)
    Table 30. Global Poliomycetes Vaccine Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Poliomycetes Vaccine Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Poliomycetes Vaccine Sales in Volume by Country (2017-2028) & (K Doses)
    Table 33. North America Poliomycetes Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Poliomycetes Vaccine Sales in Volume by Region (2017-2028) & (K Doses)
    Table 35. Asia Pacific Poliomycetes Vaccine Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Poliomycetes Vaccine Sales in Volume by Country (2017-2028) & (K Doses)
    Table 37. Europe Poliomycetes Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Poliomycetes Vaccine Sales in Volume by Country (2017-2028) & (K Doses)
    Table 39. Latin Americaa Poliomycetes Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Poliomycetes Vaccine Sales in Volume by Country (2017-2028) & (K Doses)
    Table 41. Middle East and Africa Poliomycetes Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Sanofi S.A Corporation Information
    Table 43. Sanofi S.A Description and Business Overview
    Table 44. Sanofi S.A Poliomycetes Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 45. Sanofi S.A Poliomycetes Vaccine Product
    Table 46. Sanofi S.A Recent Development
    Table 47. United Pharma Industries Co Ltd Corporation Information
    Table 48. United Pharma Industries Co Ltd Description and Business Overview
    Table 49. United Pharma Industries Co Ltd Poliomycetes Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 50. United Pharma Industries Co Ltd Product
    Table 51. United Pharma Industries Co Ltd Recent Development
    Table 52. Gansu Conbest Biotech Co., Ltd. Corporation Information
    Table 53. Gansu Conbest Biotech Co., Ltd. Description and Business Overview
    Table 54. Gansu Conbest Biotech Co., Ltd. Poliomycetes Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 55. Gansu Conbest Biotech Co., Ltd. Product
    Table 56. Gansu Conbest Biotech Co., Ltd. Recent Development
    Table 57. Shenzhen Mellow Hope Pharm Industrial Co., Ltd. Corporation Information
    Table 58. Shenzhen Mellow Hope Pharm Industrial Co., Ltd. Description and Business Overview
    Table 59. Shenzhen Mellow Hope Pharm Industrial Co., Ltd. Poliomycetes Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 60. Shenzhen Mellow Hope Pharm Industrial Co., Ltd. Product
    Table 61. Shenzhen Mellow Hope Pharm Industrial Co., Ltd. Recent Development
    Table 62. China National Biotec Group Corporation Information
    Table 63. China National Biotec Group Description and Business Overview
    Table 64. China National Biotec Group Poliomycetes Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 65. China National Biotec Group Product
    Table 66. China National Biotec Group Recent Development
    Table 67. Serum Institute of India Corporation Information
    Table 68. Serum Institute of India Description and Business Overview
    Table 69. Serum Institute of India Poliomycetes Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 70. Serum Institute of India Product
    Table 71. Serum Institute of India Recent Development
    Table 72. Key Raw Materials Lists
    Table 73. Raw Materials Key Suppliers Lists
    Table 74. Poliomycetes Vaccine Customers List
    Table 75. Poliomycetes Vaccine Distributors List
    Table 76. Research Programs/Design for This Report
    Table 77. Key Data Information from Secondary Sources
    Table 78. Key Data Information from Primary Sources
List of Figures
    Figure 1. Poliomycetes Vaccine Product Picture
    Figure 2. Global Poliomycetes Vaccine Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Poliomycetes Vaccine Market Size 2017-2028 (US$ Million)
    Figure 4. Global Poliomycetes Vaccine Sales 2017-2028 (K Doses)
    Figure 5. United States Poliomycetes Vaccine Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Poliomycetes Vaccine Market Size 2017-2028 (US$ Million)
    Figure 7. United States Poliomycetes Vaccine Sales 2017-2028 (K Doses)
    Figure 8. United States Poliomycetes Vaccine Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Poliomycetes Vaccine Market Share in Global, in Volume (K Doses) 2017-2028
    Figure 10. Poliomycetes Vaccine Report Years Considered
    Figure 11. Product Picture of Type 1
    Figure 12. Product Picture of Type 2
    Figure 13. Global Poliomycetes Vaccine Market Share by Type in 2022 & 2028
    Figure 14. Global Poliomycetes Vaccine Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Poliomycetes Vaccine Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Poliomycetes Vaccine Sales by Type (2017-2028) & (K Doses)
    Figure 17. Global Poliomycetes Vaccine Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Poliomycetes Vaccine Price by Type (2017-2028) & (USD/Dose)
    Figure 19. United States Poliomycetes Vaccine Market Share by Type in 2022 & 2028
    Figure 20. United States Poliomycetes Vaccine Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Poliomycetes Vaccine Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Poliomycetes Vaccine Sales by Type (2017-2028) & (K Doses)
    Figure 23. United States Poliomycetes Vaccine Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Poliomycetes Vaccine Price by Type (2017-2028) & (USD/Dose)
    Figure 25. Product Picture of Hospitals
    Figure 26. Product Picture of Clinics
    Figure 27. Product Picture of Others
    Figure 28. Global Poliomycetes Vaccine Market Share by Application in 2022 & 2028
    Figure 29. Global Poliomycetes Vaccine Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 30. Global Poliomycetes Vaccine Sales Market Share in Value by Application (2017-2028)
    Figure 31. Global Poliomycetes Vaccine Sales by Application (2017-2028) & (K Doses)
    Figure 32. Global Poliomycetes Vaccine Sales Market Share in Volume by Application (2017-2028)
    Figure 33. Global Poliomycetes Vaccine Price by Application (2017-2028) & (USD/Dose)
    Figure 34. United States Poliomycetes Vaccine Market Share by Application in 2022 & 2028
    Figure 35. United States Poliomycetes Vaccine Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 36. United States Poliomycetes Vaccine Sales Market Share in Value by Application (2017-2028)
    Figure 37. United States Poliomycetes Vaccine Sales by Application (2017-2028) & (K Doses)
    Figure 38. United States Poliomycetes Vaccine Sales Market Share in Volume by Application (2017-2028)
    Figure 39. United States Poliomycetes Vaccine Price by Application (2017-2028) & (USD/Dose)
    Figure 40. North America Poliomycetes Vaccine Sales in Volume Growth Rate 2017-2028 (K Doses)
    Figure 41. North America Poliomycetes Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 42. U.S. Poliomycetes Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Canada Poliomycetes Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Europe Poliomycetes Vaccine Sales in Volume Growth Rate 2017-2028 (K Doses)
    Figure 45. Europe Poliomycetes Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 46. Germany Poliomycetes Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. France Poliomycetes Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. U.K. Poliomycetes Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Italy Poliomycetes Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Russia Poliomycetes Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Asia-Pacific Poliomycetes Vaccine Sales in Volume Growth Rate 2017-2028 (K Doses)
    Figure 52. Asia-Pacific Poliomycetes Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 53. China Poliomycetes Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Japan Poliomycetes Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. South Korea Poliomycetes Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. India Poliomycetes Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Australia Poliomycetes Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Taiwan Poliomycetes Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Indonesia Poliomycetes Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Thailand Poliomycetes Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Malaysia Poliomycetes Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Philippines Poliomycetes Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Latin America Poliomycetes Vaccine Sales in Volume Growth Rate 2017-2028 (K Doses)
    Figure 64. Latin America Poliomycetes Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 65. Mexico Poliomycetes Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Brazil Poliomycetes Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Argentina Poliomycetes Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Middle East & Africa Poliomycetes Vaccine Sales in Volume Growth Rate 2017-2028 (K Doses)
    Figure 69. Middle East & Africa Poliomycetes Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 70. Turkey Poliomycetes Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Saudi Arabia Poliomycetes Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. U.A.E Poliomycetes Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Poliomycetes Vaccine Value Chain
    Figure 74. Poliomycetes Vaccine Production Process
    Figure 75. Channels of Distribution
    Figure 76. Distributors Profiles
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed